| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $58M |
Buys | $1,005,161 | 17 | 100 |
Sells | $0 | 0 | 0 |
| Spoor Johan M. | CEO | 4 | $307,703 | 0 | $0 | $307,703 |
| Williamson Robert F III | director | 5 | $270,879 | 0 | $0 | $270,879 |
| Woods Lori A | director | 3 | $149,982 | 0 | $0 | $149,982 |
| Hunt Jonathan Robert | Chief Financial Officer | 3 | $101,648 | 0 | $0 | $101,648 |
| HENSON HEIDI | director | 1 | $100,004 | 0 | $0 | $100,004 |
| Graham Juan | Chief Financial Officer | 1 | $74,946 | 0 | $0 | $74,946 |
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
Over the last 12 months, insiders at Perspective Therapeutics, Inc. have bought $1.01M and sold $0 worth of Perspective Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Perspective Therapeutics, Inc. have bought $29.37M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Spoor Johan M. (CEO) — $307,703. Williamson Robert F III (director) — $270,879. Woods Lori A (director) — $149,982.
The last purchase of 23,475 shares for transaction amount of $49,999 was made by Woods Lori A (director) on 2025‑03‑31.
| 2025-03-31 | Woods Lori A | director | 23,475 0.0317% | $2.13 | $49,999 | +8.69% | ||
| 2025-03-31 | Williamson Robert F III | director | 38,145 0.0518% | $2.14 | $81,775 | +8.69% | ||
| 2025-03-28 | Williamson Robert F III | director | 22,192 0.0339% | $2.27 | $50,376 | +3.75% | ||
| 2025-03-28 | Spoor Johan M. | Chief Executive Officer | 26,676 0.0401% | $2.24 | $59,673 | +3.75% | ||
| 2025-03-28 | Graham Juan | Chief Financial Officer | 33,333 0.0504% | $2.25 | $74,946 | +3.75% | ||
| 2024-12-04 | Spoor Johan M. | CEO | 8,000 0.0119% | $3.77 | $30,132 | -26.95% | ||
| 2024-12-04 | HENSON HEIDI | director | 25,975 0.0396% | $3.85 | $100,004 | -26.95% | ||
| 2024-11-25 | Williamson Robert F III | director | 6,266 0.0078% | $3.64 | $22,814 | -25.20% | ||
| 2024-11-25 | Spoor Johan M. | CEO | 26,500 0.0342% | $3.79 | $100,468 | -25.20% | ||
| 2024-11-25 | Hunt Jonathan Robert | Chief Financial Officer | 12,829 0.0167% | $3.82 | $48,974 | -25.20% | ||
| 2024-06-17 | Hunt Jonathan Robert | Chief Financial Officer | 1,800 0.006% | $9.81 | $17,667 | -62.96% | ||
| 2024-06-14 | Woods Lori A | director | 4,587 0.017% | $10.90 | $49,990 | -63.41% | ||
| 2024-06-13 | Spoor Johan M. | CEO | 100,000 0.0399% | $1.17 | $117,430 | -65.52% | ||
| 2024-06-03 | Woods Lori A | director | 34,246 0.017% | $1.46 | $49,992 | -68.25% | ||
| 2024-05-31 | Williamson Robert F III | director | 55,000 0.0258% | $1.38 | $75,900 | -68.30% | ||
| 2024-05-31 | Hunt Jonathan Robert | Chief Financial Officer | 25,006 0.0119% | $1.40 | $35,007 | -68.30% | ||
| 2024-05-29 | Williamson Robert F III | director | 30,031 0.0136% | $1.33 | $40,014 | -60.85% | ||
| 2024-03-06 | Lantheus Alpha Therapy, LLC | 10 percent owner | 60.43M 19.5267% | $0.95 | $57.41M | +18.53% | ||
| 2024-01-30 | Williamson Robert F III | director | 127,206 0.0309% | $0.71 | $90,710 | +60.99% | ||
| 2024-01-29 | Williamson Robert F III | director | 25,266 0.0055% | $0.64 | $16,170 | +79.91% |
| Woods Lori A | director | 183460 0.2472% | $519,191.80 | 3 | 0 | |
| Williamson Robert F III | director | 108982 0.1468% | $308,419.06 | 10 | 0 | +103.36% |
| Spoor Johan M. | Chief Executive Officer | 59383 0.08% | $168,053.89 | 4 | 0 | |
| Hunt Jonathan Robert | Chief Financial Officer | 48800 0.0657% | $138,104.00 | 3 | 0 | |
| Graham Juan | Chief Financial Officer | 35354 0.0476% | $100,051.82 | 1 | 0 | |
| HENSON HEIDI | director | 25975 0.035% | $73,509.25 | 1 | 0 | |
| Lantheus Alpha Therapy, LLC | 10 percent owner | 116773394 157.3165% | $330.47M | 1 | 0 | +18.53% |
| Puhlmann Markus | Chief Medical Officer | 1375425 1.853% | $3.89M | 1 | 0 | +147.24% |
$1,105,104 | 34 | -11.40% | $361.51M | |
$4,857,655 | 34 | -32.19% | $5.21M | |
$167,957 | 12 | -9.47% | $68.13M | |
Perspective Therapeutics, Inc. (CATX) | $57,744,037 | 7 | 97.51% | $210.07M |
$24,971 | 6 | -37.72% | $35.02M | |
$21,637 | 4 | -55.86% | $2.88M | |
$12,661,990 | 3 | 81.20% | $36.68M | |
$9,786 | 2 | -56.58% | $3.08M | |
$13,650 | 1 | -48.97% | $8.88M |
| Increased Positions | 49 | +27.07% | 6M | +11.92% |
| Decreased Positions | 78 | -43.09% | 7M | -15.4% |
| New Positions | 15 | New | 3M | New |
| Sold Out Positions | 37 | Sold Out | 3M | Sold Out |
| Total Postitions | 152 | -16.02% | 46M | -3.48% |
| Fmr Llc | $25,670.00 | 13.55% | 10.03M | +5M | +82.16% | 2024-12-31 |
| Blackrock, Inc. | $10,167.00 | 5.37% | 3.97M | -133,722 | -3.26% | 2025-03-31 |
| Vanguard Group Inc | $8,051.00 | 4.25% | 3.14M | +67,926 | +2.21% | 2024-12-31 |
| Deerfield Management Company, L.P. (Series C) | $7,523.00 | 3.97% | 2.94M | +120,991 | +4.29% | 2024-12-31 |
| Avidity Partners Management Lp | $6,898.00 | 3.64% | 2.69M | -749,402 | -21.76% | 2024-12-31 |
| Octagon Capital Advisors Lp | $5,900.00 | 3.12% | 2.3M | +882,528 | +62.05% | 2024-12-31 |
| Nicholson Wealth Management Group, Llc | $4,120.00 | 2.17% | 1.61M | +7,000 | +0.44% | 2024-12-31 |
| Affinity Asset Advisors, Llc | $3,328.00 | 1.76% | 1.3M | +800,000 | +160% | 2024-12-31 |
| Millennium Management Llc | $3,316.00 | 1.75% | 1.3M | +1M | New | 2024-12-31 |
| Perceptive Advisors Llc | $3,047.00 | 1.61% | 1.19M | +1M | New | 2024-12-31 |